Respiratory Research Review

Dr. Lutz Beckert

Welcome to this edition of the Respiratory Research Review and thank you for the feedback.

"TB anywhere, TB everywhere" - this was the motto of the last WHO World TB day. It seems timely to review the data on increasing TB drug resistance in the United Kingdom. Researchers from Japan, Canada, America, France and Germany apply themselves to improving our control and early detection programmes, in particular the use of gamma interferon-based systems.

In this edition of the Respiratory Research Review, we also review new evidence in the management of pulmonary embolism and the disappointing outcome of combination therapy for smoking cessation.

Kind regards

Dr. Lutz Beckert
lutzbeckert@researchreview.co.nz

Respiratory Research Review	Contents
Issue 21 (2008)	Diagnosing pulmonary MAC with enzyme immunoassay Antituberculosis drug resistance in the UK Predictive value of IFN-γ assay in recent TB infection IFN-γ release assay to diagnose latent TB infection QuantiFERON TB-2G test in elderly TB patients Model for efficient screening of TB contacts Nortriptyline plus NRT in smoking cessation Safety of LABAs in stable COPD Pneumonia in elderly patients with COPD Diagnosing PE by multidetector CT +/- venous ultrasound
Issue 20 (2008)	Time to antibiotics and pneumonia diagnosis Chest x-ray and time to antibiotics in pneumonia PPV and CAP outcomes Thin-section CT and lung tumour prognosis Hypoxia test cut-offs in neonatal CLD Hypoxia tests to predict in-flight hypoxaemia HCT for predicting in-flight hypoxia in preterms Extrapulmonary COPD effects and physical activity Dust mite control in asthma Chronic community beryllium exposure LB and lung transplant outcomes
Issue 19 (2008)	Dyspnoea and airway responses in obesity Single versus bilateral lung transplantation Cotton dust exposure and lung function Wood dust effects on lung function Variations in COPD exacerbation analyses Snoring and chronic bronchitis Effect of macrolides on airway hypersecretion β-blocker use for CV disease in COPD FEV₆ and FVC for predicting lung capacity rhDNase for acute asthma in children
Issue 18 (2008)	VTE risk in acute hospitalisation VTE risk with minor injuries Assessing LV/RV ratio in PE Concomitant coumarins and SSRIs Outcomes following DVT and PE Thrombocytopenia with heparin: incidence and impact TE risk with warfarin interruptions Cannabis and lung cancer risk Cannabis and bullous lung disease Lung clearance index in CF
Issue 17 (2008)	Young people, money & access to tobacco ICU outcome & prognosis for lung cancer patients Spirometry in general practice Management of primary spontaneous pneumothorax Nasal surgery in OSA Auto-CPAP versus fixed-CPAP in OSA Chronic sleep restriction & daytime sleepiness Salmeterol/fluticasone vs tiotropium for COPD exacerbations Bosentan for idiopathic pulmonary fibrosis Cyclophosphamide in scleroderma interstitial lung disease
Issue 16 (2008)	Lung disease and safety of air travel Diagnosis of PE in hospitalised patients CTPA vs VQ for suspected PE Fatal PE risk after cessationof VTE anticoagulant therapy ADRB2 polymorphisms and response to long-acting ß2-agonists Flexible bronchoscopy in patients with chronic cough Second-hand smoke and quality of life Hospitalisation rates for COPD in Australia Predictors of hospital admission for COPD Range and severity of COPD symptoms in older adults
2007 Archive
2006 Archive